Drugs Archives - Page 43 of 66 - ��ýҕ�l Health News

Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ For Dummies

The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.

Feb. 14, 2019

Can California Beat The Federal Government In Lowering Drug Prices?

Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.

By Samantha Young

Feb. 14, 2019

Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost

For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?

By Bram Sable-Smith, Side Effects Public Media

Feb. 12, 2019

False Lead: Senator’s Offer To Help Patient Import Cheap Insulin Goes Nowhere

Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn’t appear to exist.

By Jay Hancock

Feb. 11, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 8, 2019

What ‘Dope Sick’ Really Feels Like

Just as each person’s journey into addiction is unique, different approaches work for people trying to find their way out. For me, detoxing was nightmarish. And a long-held dream come true.

By Brian Rinker

Feb. 8, 2019

Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union

Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.

Feb. 7, 2019

Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale

President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.

By Sydney Lupkin and Jay Hancock

Feb. 7, 2019

Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices

The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.

By Julie Rovner

Feb. 6, 2019

Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals

The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.

By Jay Hancock

Feb. 1, 2019

Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune

WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.

By Christine Willmsen, WBUR and Martha Bebinger, WBUR

Feb. 1, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 1, 2019

Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019

Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.

Jan. 31, 2019

Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs

Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.

By Emmarie Huetteman and Rachel Bluth

Jan. 29, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Jan. 25, 2019

Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’

Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.

By Shefali Luthra

Jan. 25, 2019

Listen: ‘Death Certificate Project’ Aims At Opioid Crisis, But Doctors Cry Foul

A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.

By April Dembosky, KQED

Jan. 23, 2019

Doctors Call California’s Probe Of Opioid Deaths A ‘Witch Hunt’

In a unique crackdown on what it sees as “excessive prescribing,” the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses — whether or not the doctors prescribed the fatal medications.

By Cheryl Clark

Jan. 23, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Jan. 18, 2019

County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing

A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.

By Victoria Knight

Jan. 18, 2019

��ýҕ�l

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs